L
Lippincott Williams Wilkins
Researcher at University of South Australia
Publications - 196
Citations - 15988
Lippincott Williams Wilkins is an academic researcher from University of South Australia. The author has contributed to research in topics: Myocardial infarction & Basic life support. The author has an hindex of 46, co-authored 195 publications receiving 15546 citations. Previous affiliations of Lippincott Williams Wilkins include National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Stroke Prevention in Atrial Fibrillation Study. Final results.
TL;DR: Aspirin and warfarin are both effective in reducing ischemic stroke and systemic embolism in patients with atrial fibrillation and patients with nonrheumatic atrialfibrillation who can safely take either aspirin or warfarIn should receive prophylactic antithrombotic therapy to reduce the risk of stroke.
Journal ArticleDOI
Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data.
TL;DR: Patients similar to those enrolled in this trial can safely defer bypass surgery until symptoms worsen to the point that surgical palliation is required.
Journal Article
ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction
Journal ArticleDOI
A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees.
TL;DR: These results confirm previous trials evidence that a progressively increasing dose of beta-blocker in severe heart failure confers functional benefit, and suggest that benefit frombeta-blockade therapy was greater for those with nonischemic cardiomyopathy.
Journal ArticleDOI
Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia.
TL;DR: In the overall trial, patients with unstable angina and NQMI were managed with low rates of mortality and myocardial infarction or reinfarction at the time of the 6-week visit and the average length of initial hospitalization, incidence of rehospitalization within 6 weeks, and days of re Hospitalization all were significantly lower.